https://digitalcommons.library.tmc.edu/uthmed_docs/1640/
"Depatuxizumab Mafodotin in EGFR-Amplified Newly Diagnosed Glioblastoma" by Andrew B Lassman,...
BACKGROUND: Approximately 50% of newly diagnosed glioblastomas (GBMs) harbor epidermal growth factor receptor gene amplification (EGFR-amp). Preclinical and...
depatuxizumab mafodotinnewly diagnosedby andrewegframplified
https://io.nihr.ac.uk/news/intervention/depatuxizumab-mafodotin-abt-414/
Depatuxizumab mafodotin (ABT-414) Archives - NIHR Innovation Observatory
depatuxizumab mafodotinabtarchivesnihrinnovation